Advent International, the US private equity firm behind some of the biggest leveraged buyouts and conglomerate carve-outs, including the ₹17.2-billion acquisition of Thyssenkrupps elevator business in 2020 along with co-investors and the 1.8 billion joint takeover of Royal Bank of Scotlands payments business, Worldpay, believes India is among the worlds most attractive markets where investments of up to $10 billion in the next five years are likely.
Advent International believes that Indian valuations are not a barrier to making deals, as they are relative to growth opportunities and risk returns. The firm views the premium valuations in India as a reflection of the significant growth opportunities and the relative attractiveness of the market. Last year alone, it invested $7 billion in new opportunities ranging from cybersecurity to pharma, but more importantly, realised $8.4 billion via exits — higher than their previous five-year average of $5.7 billion.
US-based private equity firm Advent International is looking at making investments of $5-10 billion in India over the next five years, a media report said.
The ..
Advent announced its acquisition of Suven Pharma in December. Including the cost of the open offer, the deal size would go up to Rs 9,589 crore. The deal was given a green light by the union cabinet on September 14. A Suven Pharma-Cohance combination could bring together the strong client base of the former, which is a drug development partner to large global pharmaceutical companies.
Advent International announces the completion of the acquisition of Suven Pharma equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.